SCHEMBL7330308

SCHEMBL7330308

CCOC(=O)CN(C(=O)[C@H](CC(=O)OC(C)(C)C)NS(=O)(=O)c1ccc(C(C)(C)C)cc1)C1CC1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
EEF2K O00418 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
F10 P00742 2/20 0.37
MMP13 P45452 4/20 0.36
SLC1A2 P43004 1/20 0.36
POLB P06746 1/20 0.36
ELANE P08246 1/20 0.35
HSD11B1 P28845 1/20 0.35
HCRTR2 O43614 1/20 0.35
ITGB3 P05106 1/20 0.34
ITGAV P06756 1/20 0.34
ITGA2B P08514 1/20 0.34
HIF1A Q16665 1/20 0.34
F2 P00734 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7343087 0.94 EEF2K (0.40) ALDH1A1MAPTEEF2KMMP13SLC1A2
SCHEMBL8716303 0.91 EEF2K (0.46) ALDH1A1MAPTEEF2KMEN1KMT2A
SCHEMBL7335977 0.90 MMP13 (0.43) MMP13F2
SCHEMBL7302360 0.86 ACACB (0.45) F10F2
SCHEMBL7332989 0.84 F2 (0.47) F10F2
SCHEMBL8721787 0.84 EEF2K (0.46) ALDH1A1MAPTEEF2KMMP13SLC1A2
SCHEMBL7332615 0.83 F2 (0.49) F10F2
SCHEMBL8719583 0.82 F2 (0.48) F10F2
SCHEMBL7338481 0.82 F2 (0.43) F10SLC1A2ITGB3ITGA2BF2
SCHEMBL7298351 0.80 F2 (0.43) ALDH1A1MAPTF10MMP13POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0559046-B1 N-amidinopiperidinyl(3/4)- or N-amidino-1,4-Oxazinyl(2)-substituted sulfonamides, process for their preparation and use as thrombin inhibitors HOFFMANN LA ROCHE (CH) 2001-07-11 EP disclosed
EP-0559046-A1 N-amidinopiperidinyl(3/4)- or N-amidino-1,4-Oxazinyl(2)-substituted sulfonamides, process for their preparation and use as thrombin inhibitors F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) 1993-09-08 EP disclosed